CoChat
Sign Up
Cited by 30Cervical Cancer and HPV ResearchWomen's cancer prevention and managementGlobal Cancer Incidence and Screening

The DOI matches its Crossref record.

Cervical Cancer Screening Among Young Adult Women in the United States

Open access
Roland, Katherine B., Benard, Vicki B., Soman, Ashwini, Breen, Nancy, Kepka, Deanna, Saraiya, Mona·2013·Cancer Epidemiology, Biomarkers & Prevention
DOI 10.1158/1055-9965.epi-12-1266PMC PMC4480768
Open this paper in CoChat — free account

Abstract

Background: Cervical cancer screening guidelines have evolved significantly in the last decade for young adult women, with current recommendations promoting later initiation and longer intervals. Methods: Using self-reported cross-sectional National Health Interview Survey (NHIS) 2000–2010 data, trends in Papanicolaou (Pap) testing among women ages 18–29 years were examined. NHIS 2010 data were used to investigate age at first Pap test (N = 2,198), time since most recent Pap test (n = 1,622), and predictors of Pap testing within the last 12 months (n = 1,622). Results: The percentage of 18-year-olds who reported ever having a Pap test significantly decreased from 49.9% in 2000 to 37.9% in 2010. Mean age at first Pap test in 2010 was significantly younger for non-Hispanic black women (16.9 years), women < high school education (16.9 years), women who received the HPV vaccine (17.1 years), and women who have ever given birth (17.3 years). The majority reported their last Pap test within the previous 12 months (73.1%). Usual source of healthcare (OR, 2.31) and current birth control use (OR, 1.64) significantly increased chances of having a Pap test within the previous 12 months. Conclusions: From 2000 to 2010, there was a gradual decline in Pap test initiation among 18-year-olds; however, in 2010, many women reported ≤12 months since last screening. Evidence-based guidelines should be promoted, as screening young adult women for cervical cancer more frequently than recommended can cause considerable harms. Impact: A baseline of cervical cancer screening among young adult women in the United States to assess adherence to evidence-based screening guidelines. Cancer Epidemiol Biomarkers Prev; 22(4); 580–8. ©2013 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-12-1266

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 48

  1. Cannistra, 1996, Cancer of the uterine cervix, N Engl J Med, 334, 1030, 10.1056/NEJM199604183341606 · DOI
  2. Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 · DOI
  3. Bosch, 2002, The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, 55, 244, 10.1136/jcp.55.4.244 · DOI
  4. Centers for Disease Control and Prevention, 2012, Human papillomavirus-associated cancers-United States, 2004–2008, MMWR Morb Mortal Wkly Rep, 61, 258
  5. Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F · DOI
  6. zur Hausen, 2000, Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis, J Natl Cancer Inst, 92, 690, 10.1093/jnci/92.9.690 · DOI
  7. Dunne, 2011, Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States–National Health And Nutrition Examination Survey, 2003–2006: opportunity to measure HPV vaccine impact?, J Infect Dis, 204, 562, 10.1093/infdis/jir342 · DOI
  8. Mosher, 2005, Sexual behavior and selected health measures: men and women 15–44 years of age, United States, 2002, Adv Data, 1
  9. Plummer, 2007, A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion, J Infect Dis, 195, 1582, 10.1086/516784 · DOI
  10. Rodriguez, 2008, Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections, J Natl Cancer Inst, 100, 513, 10.1093/jnci/djn044 · DOI
  11. Schiffman, 2011, Human papillomavirus testing in the prevention of cervical cancer, J Natl Cancer Inst, 103, 368, 10.1093/jnci/djq562 · DOI
  12. U.S. Preventive Services Task Force, Guide to Clinical Preventive Services 2nd Edition; 9. Screening for Cervical Cancer
  13. ACOG committee opinion, 1995, Recommendations on frequency of Pap test screening. Number 152–March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists, Int J Gynaecol Obstet, 49, 210, 10.1016/0020-7292(95)90306-2 · DOI
  14. Smith, 2000, American Cancer Society guidelines for the early detection of cancer, CA Cancer J Clin, 50, 34, 10.3322/canjclin.50.1.34 · DOI
  15. U.S. Preventive Services Task Force, 2003, Screening for cervical cancer
  16. ACOG Practice Bulletin No. 131, 2012, Screening for cervical cancer, Obstet Gynecol, 120, 1222, 10.1097/AOG.0b013e318277c92a · DOI
  17. Moyer, 2012, Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 156, 880, 10.7326/0003-4819-156-12-201206190-00424 · DOI · Paper page
  18. Saslow, 2012, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer, CA Cancer J Clin, 62, 147, 10.3322/caac.21139 · DOI
  19. Sawaya, 2009, Cervical-cancer screening–new guidelines and the balance between benefits and harms, N Engl J Med, 361, 2503, 10.1056/NEJMp0911380 · DOI
  20. Arbyn, 2008, Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis, BMJ, 337, a1284, 10.1136/bmj.a1284 · DOI · Paper page
  21. Idestrom, 2003, Women's experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1, Acta Obstet Gynecol Scand, 82, 756
  22. Monsonego, 2011, Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries, BMC Womens Health, 11, 18, 10.1186/1472-6874-11-18 · DOI
  23. 2011, The “Top 5” lists in primary care: meeting the responsibility of professionalism, Arch Intern Med, 171, 1385, 10.1001/archinternmed.2011.231 · DOI
  24. Bentley, 2008, Waste in the U.S. Health care system: a conceptual framework, Milbank Q, 86, 629, 10.1111/j.1468-0009.2008.00537.x · DOI
  25. Habbema, 2012, Cervical cancer screening in the United States and the Netherlands: a tale of two countries, Milbank Q, 90, 5, 10.1111/j.1468-0009.2011.00652.x · DOI
  26. Sirovich, 2005, Screening for cervical cancer: will women accept less?, Am J Med, 118, 151, 10.1016/j.amjmed.2004.08.021 · DOI
  27. Solomon, 2007, Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines, CA Cancer J Clin, 57, 105, 10.3322/canjclin.57.2.105 · DOI
  28. Vesco, 2011, Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force, Ann Intern Med, 155, 698, 10.7326/0003-4819-155-10-201111150-00377 · DOI
  29. 2013, Centers for Disease Control and Prevention. Cervical cancer screening among women aged 18–30 years - United States, 2000–2010, MMWR Morb Mortal Wkly Rep, 61, 1038
  30. Hewitt, 2002, Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth, Am J Public Health, 92, 666, 10.2105/AJPH.92.4.666 · DOI
  31. Ashok, 2012, Recency of pap testing and future testing plans among women aged 18–64: analysis of the 2007 health information national trends survey, J Womens Health (Larchmt), 21, 705, 10.1089/jwh.2012.3562 · DOI
  32. Centers for Disease Control and Prevention, 2012, Cancer screening - United States, 2010, MMWR Morb Mortal Wkly Rep, 61, 41
  33. Coughlin, 2008, Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002, Soc Sci Med, 66, 260, 10.1016/j.socscimed.2007.09.009 · DOI
  34. Selvin, 2003, Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women, Am J Public Health, 93, 618, 10.2105/AJPH.93.4.618 · DOI
  35. Gavin, 2009, Sexual and reproductive health of persons aged 10–24 years - United States, 2002–2007, MMWR Surveill Summ, 58, 1
  36. Henderson, 2013, Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15–29, Prev Med, 56, 25, 10.1016/j.ypmed.2012.10.025 · DOI
  37. Saraiya, 2009, Pap testing and sexual activity among young women in the United States, Obstet Gynecol, 114, 1213, 10.1097/AOG.0b013e3181be3db4 · DOI
  38. Sirovich, 2004, The frequency of Pap smear screening in the United States, J Gen Intern Med, 19, 243, 10.1111/j.1525-1497.2004.21107.x · DOI
  39. Roland, 2011, Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States, Am J Obstet Gynecol, 205, 447, 10.1016/j.ajog.2011.06.001 · DOI
  40. Saraiya, 2010, Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?, Arch Intern Med, 170, 977, 10.1001/archinternmed.2010.134 · DOI
  41. Hewitt, 2004, Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey, Prev Med, 39, 270, 10.1016/j.ypmed.2004.03.035 · DOI
  42. Worthington, 2012, Adherence over time to cervical cancer screening guidelines: insights from the Canadian National Population Health Survey, J Womens Health (Larchmt), 21, 199, 10.1089/jwh.2010.2090 · DOI
  43. Henderson, 2010, Pelvic examinations and access to oral hormonal contraception, Obstet Gynecol, 116, 1257, 10.1097/AOG.0b013e3181fb540f · DOI
  44. Stewart, 2001, Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence, JAMA, 285, 2232, 10.1001/jama.285.17.2232 · DOI
  45. Howard, 2009, Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis, Cancer Causes Control, 20, 1, 10.1007/s10552-008-9228-4 · DOI
  46. Klungsoyr, 2009, Validity of self-reported Pap smear history in Norwegian women, J Med Screen, 16, 91, 10.1258/jms.2009.008087 · DOI
  47. Newell, 2000, Accuracy of patients' recall of Pap and cholesterol screening, Am J Public Health, 90, 1431, 10.2105/AJPH.90.9.1431 · DOI
  48. 2012, Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13–17 years - United States, 2011, MMWR Morb Mortal Wkly Rep, 61, 671

Cited by

Sorted by citations

See all 30

Metadata

Authors
Roland, K. B., Benard, V. B., Soman, A., Breen, N., Kepka, D., & Saraiya, M.
Affiliations
Centers for Disease Control and Prevention (US)
Corresponding author
Roland, Katherine B.
ORCID
Venue
Cancer Epidemiology, Biomarkers & Prevention
Publisher
American Association for Cancer Research (AACR)
Published
2013-04-01
Volume
22
Issue
4
Pages
580-588
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
DOI
10.1158/1055-9965.epi-12-1266
PMC
PMC4480768
OpenAlex
W2121191606
Cited by
30
References
0
Citations by year
2025: 2 · 2024: 4 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 2
FWCI
3.40
Type
journal article
Language
en
Open access
Locations
  • Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (CC999999)
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
cervical cancer screening, young adult women, Pap smear, screening guidelines, screening frequency, HPV vaccination, contraceptive use, non-Hispanic Black women, screening adherence, National Health Interview Survey
MeSH terms
Adolescent, Adult, Uterine Cervical Neoplasms, Cross-Sectional Studies, Ethnicity, Female, Humans, Health Knowledge, Attitudes, Practice, Neoplasm Staging, Prognosis, Surveys and Questionnaires, Socioeconomic Factors, Vaginal Smears, Papillomaviridae, Papillomavirus Infections, Papillomavirus Vaccines, Early Detection of Cancer, Young Adult, Papanicolaou Test

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review